When Are Statins Cost-Effective in Cardiovascular Prevention? A Systematic Review of Sponsorship Bias and Conclusions in Economic Evaluations of Statins-Reference-Cited by-同舟云学术

When Are Statins Cost-Effective in Cardiovascular Prevention? A Systematic Review of Sponsorship Bias and Conclusions in Economic Evaluations of Statins

Published:2013-07-08 Issue:7 Volume:8 Page:e69462
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Catalá-López Ferrán,Sanfélix-Gimeno Gabriel,Ridao Manuel,Peiró Salvador

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference59 articles.

1. Foundations of cost-effectiveness analysis for health and medical practices;MC Weinstein;N Engl J Med,1977

2. Framework for describing and classifying decision-making systems using technology assessment to determine the reimbursement of health technologies (fourth hurdle systems);J Hutton;Int J Technol Assess Health Care,2006

3. A bibliometric review of cost-effectiveness analyses in the economic and medical literature: 1976-2006;D Greenberg;Med Decis Mak,2010

4. Bias in published cost effectiveness studies: systematic review;CM Bell;BMJ,2006

5. Comparing estimates of cost effectiveness submitted to the National Institute for Clinical Excellence (NICE) by different organisations: retrospective study;AH Miners;BMJ,2005

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost-Effectiveness of Newer Pharmacologic Treatments in Adults With Type 2 Diabetes: A Systematic Review of Cost-Effectiveness Studies for the American College of Physicians;Annals of Internal Medicine;2024-05

2. A systematic review of economic evaluations for the pharmaceutical treatment of chronic lymphocytic leukemia and acute myeloid leukemia;Expert Review of Hematology;2022-09-02

3. Industry sponsorship bias in cost effectiveness analysis: registry based analysis;BMJ;2022-06-22

4. Consolidated Health Economic Evaluation Reporting Standards (CHEERS) 2022 Explanation and Elaboration: A Report of the ISPOR CHEERS II Good Practices Task Force;Value in Health;2022-01

5. Attainment of low-density lipoprotein cholesterol goals in statin treated patients: Real-world evidence from Australia;Current Problems in Cardiology;2021-11